Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir.

AIDS (London, England)

Volumn 26, Issue 5, 2012, Pages 567-575

  Young, Jim ^a   Schäfer, Juliane ^b   Fux, Christoph A ^b   Furrer, Hansjakob ^b   Bernasconi, Enos ^b   Vernazza, Pietro ^b   Calmy, Alexandra ^b   Cavassini, Matthias ^b   Weber, Rainer ^b   Battegay, Manuel ^b   Bucher, Heiner C ^b   Swiss HIV Cohort Study, ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ATAZANAVIR; BENZOXAZINE DERIVATIVE; DRUG DERIVATIVE; EFAVIRENZ; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; LOPINAVIR; OLIGOPEPTIDE; PHOSPHONIC ACID DERIVATIVE; PYRIDINE DERIVATIVE; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TENOFOVIR;

ADULT; ARTICLE; DRUG COMBINATION; DRUG EFFECT; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY; MALE; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ADENINE; ADULT; BENZOXAZINES; DRUG THERAPY, COMBINATION; FEMALE; GLOMERULAR FILTRATION RATE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; KIDNEY; LOPINAVIR; MALE; MIDDLE AGED; OLIGOPEPTIDES; PHOSPHONIC ACIDS; PYRIDINES; REVERSE TRANSCRIPTASE INHIBITORS; RITONAVIR; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84862299720     PISSN: None     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/qad.0b013e32834f337c     Document Type: Article

References (0)